Literature DB >> 11960368

Phosphorylation of HDM2 by Akt.

Margaret Ashcroft1, Robert L Ludwig, Douglas B Woods, Terry D Copeland, H Oliver Weber, Elizabeth J MacRae, Karen H Vousden.   

Abstract

The HDM2 protein is a key regulator of the tumour suppressor, p53. Control of HDM2 function is critical for normal cell proliferation and stress responses, and it is becoming evident that multiple modifications of HDM2 can regulate its function within cells. In this study we show that HDM2 associated with the serine-threonine kinase, Akt, in response to growth factor stimulation of human primary cells. This association was concurrent with phosphorylation of Akt (at Ser 473), and resulted in elevated expression of HDM2 and enhanced nuclear localization. However, analysis of HDM2 proteins mutated at the consensus Akt recognition sites at serines 166 and 186 indicated that modification at these residues was not sufficient for the increased expression of the protein, which was blocked by the PI3 kinase inhibitor LY294002. Tryptic peptide and mutational analyses revealed evidence for an Akt phosphorylation site in HDM2 additional to the two consensus sites.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960368     DOI: 10.1038/sj.onc.1205276

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  61 in total

1.  Specificity in the activation and control of transcription factor E2F-dependent apoptosis.

Authors:  Timothy C Hallstrom; Joseph R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

2.  Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation.

Authors:  Jayne M Stommel; Geoffrey M Wahl
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

3.  Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway.

Authors:  Donggon Lyo; Limei Xu; David A Foster
Journal:  Biochem Biophys Res Commun       Date:  2010-05-08       Impact factor: 3.575

4.  An E2F1-dependent gene expression program that determines the balance between proliferation and cell death.

Authors:  Timothy C Hallstrom; Seiichi Mori; Joseph R Nevins
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

Review 5.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

6.  Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis.

Authors:  Xiaoyun Cheng; Weiya Xia; Jer-Yen Yang; Jennifer L Hsu; Chao-Kai Chou; Hui-Lung Sun; Shannon L Wyszomierski; Gordon B Mills; William J Muller; Dihua Yu; Mien-Chie Hung
Journal:  Biochem Biophys Res Commun       Date:  2010-10-30       Impact factor: 3.575

7.  Pathological signaling via platelet-derived growth factor receptor {alpha} involves chronic activation of Akt and suppression of p53.

Authors:  Hetian Lei; Gisela Velez; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2011-02-28       Impact factor: 4.272

8.  The phenotype of MDM2 auto-degradation after DNA damage is due to epitope masking by phosphorylation.

Authors:  Qian Cheng; Jiandong Chen
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

9.  The co-treatment of metformin with flavone synergistically induces apoptosis through inhibition of PI3K/AKT pathway in breast cancer cells.

Authors:  Zhaodi Zheng; Wenzhen Zhu; Bingwu Yang; Rongfei Chai; Tingting Liu; Fenglin Li; Guanghui Ren; Shuhua Ji; Shan Liu; Guorong Li
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

10.  Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization.

Authors:  V Gama; J A Gomez; L D Mayo; M W Jackson; D Danielpour; K Song; A L Haas; M J Laughlin; S Matsuyama
Journal:  Cell Death Differ       Date:  2009-02-27       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.